CRISPR-Cas9 In Vivo Gene Editing for Transthyretin AmyloidosisJulian D. Gillmore, David Lebwohl, Marianna Fontana et al.|New England Journal of Medicine|2021Cited by 1.7k
CRISPR-Cas9 in vivo gene editing for transthyretin amyloidosisJulian D. Gillmore, David Lebwohl, Ed Gane et al.|Yearbook of pediatric endocrinology|2022Cited by 47